BioPhorum

Clarifying the misunderstandings associated with visual inspections, this paper talks about the key subjects of regulations, criticality and detectability, probability of detection, qualification vs. detection, and – importantly – why criticality and detectability of defects do not correlate.

Read more here - https://okt.to/zBaG8q

Introducing BioPhorum Council – taking back increased value to your organization

You can listen to the podcast here - https://okt.to/7vPDNO

Clare Simpson, Client Service Director, talks us through the concept of BioPhorum Council. What initiated the idea, and what opportunities will it provide? How will the Council feed into the work being advanced at the phorum and workstream level and who should be participating? Listen now to learn about this exciting launch, and then get in touch by contacting [email protected]

Explaining the current state of integration models and the challenges faced by the industry, this paper is essential reading for business leaders in biomanufacturers and contract organizations, as well as digital leaders, integration, and IT solution providers providing operational and analytics systems.

Read more here - https://okt.to/WVxrko

There is still time to register for our upcoming webinar - Supporting particle investigations with risk-based decision-making

Wednesday, 30 November 2022 - 10:00 - 11:00 EST,
15-00 - 16:00 BST, 16:00 - 17:00 CET

The presence of visible particles in parenteral medicines is a perennial issue for the industry. How do companies manage particles when they are found, especially when atypical in nature? What can companies do to assess the risk of a particle, and how can a particle impact the future of a batch of a biopharmaceutical product?

Follow the link for more details and to register here - https://okt.to/FSgc4P